Profile
James Clayburn la Force served as a Director for multiple firms including BlackRock Advantage Term Trust, Inc., BlackRock Broad Investment Grade 2009 Term Trust, Inc., BlackRock Income Trust, Inc., Blackrock Investment Quality Term Trust Inc., BlackRock Income Opportunity Trust, Inc., BlackRock High Yield Trust, Arena Pharmaceuticals, Inc., BlackRock Core Bond Trust, BlackRock Strategic Bond Trust, CancerVax Corp., Black Hawk Mining, Inc., BlackRock Ltd.
Duration Income Trust, BlackRock Municipal 2020 Term Trust, and BlackRock Dividend Achievers Trust.
Prior to his director roles, he served as the Dean of the University of California, Los Angeles in 1993.
He received his graduate and doctorate degrees from the University of California, Los Angeles and his undergraduate degree from San Diego State University.
Former positions of James Clayburn la Force
| Companies | Position | End |
|---|---|---|
| BlackRock Broad Investment Grade 2009 Term Trust, Inc. | Director/Board Member | 2009-11-08 |
| BlackRock Advantage Term Trust, Inc. | Director/Board Member | 2009-11-03 |
| Black Hawk Mining, Inc. | Director/Board Member | 2007-12-04 |
| CancerVax Corp. | Director/Board Member | 2006-05-08 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Director/Board Member | 2006-05-04 |
Training of James Clayburn la Force
| San Diego State University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
BlackRock High Yield Trust
 BlackRock High Yield Trust Investment Trusts/Mutual FundsMiscellaneous BlackRock High Yield Trust is a close-end investment fund/investment trust. Its investing objective is to provide generate high current income and to a lesser extent, and if it is consistent with its primary objective, the Fund will also seek capital appreciation, by investing in a diversified portfolios. The fund was founded on December 31, 1998 and is headquartered in Wilmington, DE. | Miscellaneous |
BlackRock Core Bond Trust
 BlackRock Core Bond Trust Investment Trusts/Mutual FundsMiscellaneous BlackRock Core Bond Trust operates as a closed-end investment fund. The firm intends to provide current income and capital appreciation. Its investments include a broad range of bonds, including corporate bonds, US government and agency securities and mortgage-related securities. The company was founded on November 30, 2001 and is headquartered in Wilmington, DE. | Miscellaneous |
| Black Hawk Mining, Inc. | Non-Energy Minerals |
| BlackRock Advantage Term Trust, Inc. | Miscellaneous |
| BlackRock Broad Investment Grade 2009 Term Trust, Inc. | Miscellaneous |
BlackRock Income Trust, Inc.
 BlackRock Income Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous BlackRock Income Trust, Inc. is a closed-end investment fund. Its investment objective is to provide total return through a combination of current income and capital appreciation. The company was founded on July 31, 1988 and is headquartered in Wilmington, DE. | Miscellaneous |
BlackRock Income Opportunity Trust, Inc.
 BlackRock Income Opportunity Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous BlackRock Income Opportunity Trust, Inc. operated as a close-end investment trust. Its investment objective was to provide current income and capital appreciation. The trust's investments included a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities. BlackRock Income Opportunity Trust was founded on December 27, 1991 and was headquartered in Wilmington, DE. | Miscellaneous |
| Blackrock Investment Quality Term Trust Inc. | Miscellaneous |
BlackRock Strategic Bond Trust
 BlackRock Strategic Bond Trust Investment Trusts/Mutual FundsMiscellaneous BlackRock Strategic Bond Trust is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of current income and capital appreciation. The company was founded on February 26, 2002 and is headquartered in Wilmington, DE. | Miscellaneous |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| CancerVax Corp. | Commercial Services |
BlackRock Ltd. Duration Income Trust
 BlackRock Ltd. Duration Income Trust Investment Trusts/Mutual FundsMiscellaneous BlackRock Ltd. Duration Income Trust is a closed-end investment fund. Its investment objective is to provide current income and capital appreciation. The company was founded on July 13, 2003 and is headquartered in Wilmington, DE. | Miscellaneous |
BlackRock Municipal 2020 Term Trust
 BlackRock Municipal 2020 Term Trust Investment Trusts/Mutual FundsMiscellaneous BlackRock Municipal 2020 Term Trust is a closed-end management investment company. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company was founded on August 20, 2002 and is headquartered in Wilmington, DE. | Miscellaneous |
BlackRock Dividend Achievers Trust
 BlackRock Dividend Achievers Trust Investment Trusts/Mutual FundsMiscellaneous BlackRock Dividend Achievers Trust is a diversified, closed-end management investment company with no operating history. It's investment objective is to provide total return through a combination of current income and capital appreciation. The company was founded on September 29, 2003 and is headquartered in Wilmington, DE. | Miscellaneous |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
- Stock Market
- Insiders
- James Clayburn la Force